“The Zydus group firm’s board … approved issuing equity shares of face value of Rs 10 each on a preferential basis to Cadila Healthcare, True North, Pioneer Investment Fund and Zydus Family Trust, Zydus Wellness said in a filing to the BSE,” reported The Times of India.
Shardul Amarchand Mangaldas & Co advised
Deal value: US$ 140 million
2018-12-06
{incomplete}
Comments
No comments yet.